Search

892 Result(s)
Sort by

university-of-medical-excellence-harvard

university-of-medical-excellence-harvard

A program designed by Harvard Medical School Executive Education with the goal of accelerating clinical development and medical affairs
PRRS vaccine discovery for swine

PRRS vaccine discovery for swine

PRRS vaccine, an unexpected scientific discovery. Our team developed the first vaccine against Porcine Reproductive and Respiratory Syndrome in pigs.
FuturePack

FuturePack

Boehringer Ingelheim has built a new special machine that enables efficient and sustainable packaging of small batches.
garbage game

garbage game

Learn more about marine pollution and find out how long it takes for garbage to dissolve in the oceans.
Spesolimab Phase II data

Spesolimab Phase II data

New data published in NEJM shows spesolimab improved signs & symptoms of GPP flares
BTD for GlyT1 in Schizophrenia

BTD for GlyT1 in Schizophrenia

Boehringer Ingelheim’s Investigational Treatment for Cognitive Impairment Associated with Schizophrenia receives FDA Breakthrough Therapy Designation
Bees and biodiversity

Bees and biodiversity

At Boehringer Ingelheim we attach great importance to sustainable planting on our company site – and to protecting the bees.
Women in STEM 2022

Women in STEM 2022

Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM.
cat dog flea allergy dermatitis

cat dog flea allergy dermatitis

Find out how you can identify and treat flea allergy dermatitis, one of the most common illnesses associated with a flea infestation.
The power of our people

The power of our people

Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity.